SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES;SUZHOU SUPLEAD LIFE SCIENCES CO., LTD.
发明人:
Bing ZHOU,Cheng LUO,Yaxi YANG,Yuanyuan ZHANG,Daohai DU,Hualiang JIANG,Gang QIAO,Xinjun WANG
申请号：
US16651510
公开号：
US20200261459A1
申请日:
2018.08.29
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides a compound represented by formula I, pharmaceutically acceptable salts, enantiomers, diastereomers or racemates thereof, the preparation method thereof, the pharmaceutical composition comprising the same, and the use thereof in the preparation of a medicament for treating a disease or condition mediated by EED and/or PRC2. The compound of the present invention can be used treating PRC2-mediated diseases or conditions.
